Exam 5 Flashcards

1
Q

What are clinical manifestations of oropharyngeal candidiasis?

A

-painless, creamy white, plaque-like lesions on the buccal mucosa, hard or soft palate, oropharyngeal mucosa, or tongue surface
-dry mouth
-taste alterations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the treatment options for oropharyngeal candidiasis?

A

-fluconazole 200 mg PO once, then 100-200 mg PO QD for 7-14 days
-topical agents (nystatin or clotrimazole)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are clinical manifestations of esophageal candidiasis?

A

-fever
-retrosternal burning pain or discomfort
-dysphagia
-odynophagia
-whitish plaques with superficial ulceration of esophageal mucosa with white surface exudates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the treatment for esophageal candidiasis?

A

fluconazole 200 mg IV or PO QD for 14-21 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are clinical manifestations of vulvovaginal candidiasis?

A

-white, thick vaginal discharge
-vaginal itching
-vaginal burning
-vulvar erythema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the treatment options for uncomplicated vulvovaginal candidiasis?

A

-fluconazole 150 mg PO once
-topical azole for 3-7 days
-ibrexafungerp 300 mg PO BID for 1 day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the treatment options for severe vulvovaginal candidiasis?

A

-fluconazole 100-200 mg PO QD
-topical antifungals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the duration of therapy for severe vulvovaginal candidiasis?

A

7 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the treatment for azole-refractory C. glabrata vaginitis?

A

boric acid 600 mg vaginally QD for 14 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

When is prophylaxis recommended for candidiasis?

A

frequent or severe recurrences of esophagitis or vaginitis (QD treatment)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the clinical manifestations of cryptococcal meningitis?

A

-fever
-malaise
-headache
-nausea
-dizziness
-lethargy
-irritability
-impaired memory
-behavioral changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the treatment for the induction phase of cryptococcal meningitis?

A

amphotericin B 3-4 mg/kg IV QD and flucytosine 25 mg/kg PO QID for 2 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the treatment for the consolidation phase of cryptococcal meningitis?

A

fluconazole 800 mg PO QD for 8 weeks (400 mg if patient is stable with sterile CSF and on ART)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the treatment for the maintenance phase of cryptococcal meningitis?

A

fluconazole 200 mg PO QD ≥ 1 year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

When should ART be initiated when treating cryptococcal meningitis?

A

between the induction and consolidation phases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

When can secondary prophylaxis be discontinued for cryptococcal meningitis?

A

-duration of therapy ≥ 1 year
-asymptomatic
-CD4 count ≥ 100 cells/mm^3 for 3 months on ART

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

When should secondary prophylaxis be restarted for cryptococcal meningitis?

A

CD4 count < 100 cells/mm^3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the clinical manifestations of histoplasmosis?

A

-fever
-fatigue
-weight loss
-hepatosplenomegaly
-cough
-dyspnea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are treatment options for mild to moderate histoplasmosis?

A

-itraconazole 200 mg PO TID for 3 days, then BID for ≥ 12 months
-posaconazole
-voriconazole
-fluconazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the treatment for severe histoplasmosis?

A

amphotericin B 3 mg/kg IV QD for ≥ 2 weeks, then itraconazole 200 mg PO TID for 3 days, then BID for ≥ 12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

When should primary prophylaxis of histoplasmosis be initiated?

A

-CD4 count < 150 cells/mm^3
-high risk due to occupational exposure or living in community with hyperendemic rate of histoplasmosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the treatment for primary prophylaxis of histoplasmosis?

A

itraconazole 200 mg PO QD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

When should ART be initiated for treatment of histoplasmosis?

A

ASAP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

When may primary prophylaxis of histoplasmosis be discontinued?

A

-ART
-CD4 count ≥ 150 cells/mm^3 for 6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

When should secondary prophylaxis of histoplasmosis be initiated?

A

-severe disseminated disease or CNS infection after maintenance therapy OR
-relapse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What is the treatment for secondary prophylaxis of histoplasmosis?

A

itraconazole 200 mg PO QD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

When may secondary prophylaxis of histoplasmosis be discontinued?

A

-azole therapy for ≥ 1 year
-negative fungal blood cultures
-serum or urine histoplasma antigen below level of quantification
-ART
-CD4 count ≥ 150 cells/mm^3 for ≥ 6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

When should secondary prophylaxis of histoplasmosis be restarted?

A

CD4 count < 150 cells/mm^3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What are clinical manifestations of mycobacterium avium complex (MAC)?

A

-disseminated multi-organ infection if not on ART
-fever
-night sweats
-weight loss
-diarrhea
-abdominal pain
-malaise/fatigue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What are treatment options for MAC?

A

-clarithromycin 500 mg PO BID and ethambutol 15 mg/kg PO QD
-azithromycin 500-600 mg PO QD and ethambutol 15 mg/kg PO QD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What drug can be added to a treatment regimen for severe MAC?

A

rifabutin 300 mg PO QD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

When should more antibiotics be added to a treatment regimen for MAC?

A

-high risk of mortality
-likely drug resistance
-CD4 count < 50 cells/mm^3
-high mycobacterial loads in blood
-ineffective ART

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What antibiotics can be added to a treatment regimen for MAC?

A

-levofloxacin or moxifloxacin
-amikacin or streptomycin
-linezolid, tedizolid, or omadacycline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

When can duration of therapy for MAC be shorter?

A

CD4 count > 100 cells/mm^3 for ≥ 6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

When should ART be initiated for treatment of MAC?

A

ASAP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

When is prophylaxis not recommended for MAC?

A

if ART is initiated immediately after HIV diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

When should primary prophylaxis of MAC be initiated?

A

-CD4 count < 50 cells/mm^3
-no ART or high viral load

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

What is the treatment for primary prophylaxis of MAC?

A

azithromycin 1,200 mg PO QW

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

When should primary prophylaxis of MAC be discontinued?

A

ART

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

When should primary prophylaxis of MAC be restarted?

A

CD4 count < 50 cells/mm^3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

When should secondary prophylaxis of MAC be discontinued?

A

-completed ≥ 12 months
-asymptomatic
-CD4 count > 100 cells/mm^3 for > 6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

When should secondary prophylaxis of MAC be restarted?

A

CD4 count < 100 cells/mm^3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

What are clinical manifestations of pneumonitis jirovecii pneumonia (PJP)?

A

-dyspnea
-fever
-non-productive cough
-chest discomfort
-hypoxemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

What are treatment options for mild to moderate PJP?

A

-Bactrim 15-20 mg/kg/day PO TID
-Bactrim DS 2 tablets PO TID
-dapsone and trimethoprim
-primaquine and clindamycin
-atovaquone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

For what drugs in the treatment of PJP do G6PD levels need to be checked?

A

-dapsone
-primaquine
-clindamycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

What are treatment options for moderate to severe PJP?

A

-Bactrim 15-20 mg/kg/day IV divided Q6-8H for 21 days
-primaquine and clindamycin
-pentamidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

When should adjunctive corticosteroid therapy be initiated for PJP?

A

pO2 < 70 mm Hg (within 72 hours of PJP therapy initiation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

What is the adjunctive corticosteroid treatment for PJP?

A

prednisone 40 mg PO BID for 5 days, then QD for 5 days, then 20 mg PO QD for 11 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

When should ART be initiated for treatment of PJP?

A

within 2 weeks of PJP diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

When should primary prophylaxis of PJP be initiated?

A

-CD4 count 100-200 cells/mm^3 (if high viral load) OR
-CD4 count < 100 cells/mm^3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

When should secondary prophylaxis of PJP be initiated?

A

all patients with acute episode of PJP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

When can secondary prophylaxis of PJP be discontinued?

A

CD4 count ≥ 200 cells/mm^3 for > 3 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

When should secondary prophylaxis of PJP be restarted?

A

CD4 count < 100 cells/mm^3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

What are clinical manifestations of toxoplasmosis?

A

-headache
-focal neurologic deficits
-fever

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

What are the treatment options for acute treatment of toxoplasmosis?

A

-pyrimethamine 200 mg PO once, then weight-based dosing
-Bactrim 5 mg/kg IV or PO BID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

What is the duration of therapy for acute treatment of toxoplasmosis?

A

≥ 6 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

What are the treatment options for maintenance therapy of toxoplasmosis?

A

-pyrimethamine 25-50 mg PO QD and sulfadiazine 2,000-4,000 mg PO BID-QID and leucovorin 10-25 mg PO QD
-Bactrim DS 1 tablet PO BID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

When should primary prophylaxis of toxoplasmosis be initiated?

A

toxoplasma IgG positive with CD4 count < 100 cells/mm^3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

What is the treatment for primary prophylaxis of toxoplasmosis?

A

Bactrim DS 1 tablet PO QD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

When can primary prophylaxis of toxoplasmosis be discontinued?

A

-CD4 count > 200 cells/mm^3 for > 3 months in response to ART
-CD4 count 100-200 cells/mm^3 and low viral load for ≥ 3-6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

When should primary prophylaxis of toxoplasmosis be restarted?

A

-CD4 count < 100 cells/mm^3
-CD4 count 100-200 cells/mm^3 and high viral load

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

When can secondary prophylaxis of toxoplasmosis be discontinued?

A

-CD4 count > 200 cells/mm^3 for > 6 months
-completed initial therapy
-asymptomatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

When should secondary prophylaxis of toxoplasmosis be restarted?

A

CD4 count < 200 cells/mm^3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

What are risk factors for infections in immunocompromised patients?

A

-neutropenia
-immune system defects
-destruction of protective barriers
-environmental contamination/alteration of microbial flora

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

neutropenia

A

ANC < 1000 cells/mm^3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

What are the most common causative bacteria for neutropenia?

A

-Staphylococcus aureus
-Enterobacterales
-Pseudomonas aeruginosa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

cell-mediated immunity

A

-T-lymphocytes
-primary defense against intracellular pathogens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

humoral immunity

A

-B-lymphocytes
-primary defense against extracellular pathogens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

What can cause immune system defects?

A

-underlying disease
-immunosuppressive drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

What are protective barriers or methods that protective barriers can destroy?

A

-skin
-mucous membranes
-surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

How can mucous membranes be destructed?

A

-chemotherapy
-radiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

What type of bacteria does oropharyngeal flora rapidly change to in hospitalized patients within the first 48 hours?

A

Gram-negative bacilli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

fever in neutropenic cancer patients

A

-single oral temperature of ≥ 38.3ºC OR
-oral temperature ≥ 38ºC for ≥ 1 hour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q

What are the characteristics of low-risk neutropenia patients?

A

-anticipated neutropenia ≤ 7 days
-clinically stable
-no medical comorbidities
-outpatient at fever onset

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

What is the outpatient treatment for low-risk neutropenia?

A

PO fluoroquinolone and Augmentin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
76
Q

When are IV antibiotics indicated for low-risk neutropenic patients?

A

-inadequate outpatient infrastructure OR
-not candidate for oral regimen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
77
Q

What IV antibiotics are used for neutropenia?

A

-Zosyn
-antipseudomonal carbapenem
-cefepime
-ceftazidime

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
78
Q

What are the characteristics for high-risk neutropenia patients?

A

-anticipated neutropenia > 7 days
-clinically unstable
-medical comorbidities
-HSCT
-inpatient at fever onset
-ANC ≤ 100 cells/mm^3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
79
Q

When can IV vancomycin be added to a drug regimen for neutropenia?

A

-cellulitis
-pneumonia
-severe sepsis or shock
-Gram-positive bacteria
-suspected IV catheter infection
-MRSA
-resistant Streptococci

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
80
Q

What antibiotics can be added to a neutropenia drug regimen for septic shock, Gram-negative bacteremia, or pnuemonia?

A

-aminoglycoside
-antipseudomonal fluoroquinolone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
81
Q

What bacteria should always be covered by antibiotics for the treatment of neutropenia?

A

Pseudomonas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
82
Q

What can be used as a high-risk neutropenia drug regimen for patients with a penicillin allergy?

A

-ciprofloxacin
-aztreonam
-vancomycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
83
Q

What antibiotic is used for MRSA?

A

vancomycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
84
Q

What antibiotics are used for VRE?

A

-daptomycin
-linezolid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
85
Q

What antibiotic is used for ESBL?

A

carbapenems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
86
Q

What antibiotics are used for KPC?

A

-meropenem/vaborbactam
-imipenem/cilastatin/relebactam
-ceftazidime/avibactam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
87
Q

When should targeted therapy be re-evaluated after empiric therapy for the treatment of neutropenia?

A

48-72 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
88
Q

What is the median time of dissolution of fever for neutropenia?

A

5-7 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
89
Q

When should antifungal therapy be initiated for neutropenia?

A

-persistent fever OR
-development of new fever with undocumented infection after 4-7 days of broad spectrum antibiotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
90
Q

What are antifungal treatments for neutropenia?

A

-amphotericin B (deoxycholate or liposomal)
-azoles
-echinocandins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
91
Q

What azoles can be used to treat neutropenia?

A

-fluconazole
-voriconazole
-posaconazole
-isavuconazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
92
Q

What echinocandins can be used to treat neutropenia?

A

-micafungin
-caspofungin
-anidulafungin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
93
Q

What is the duration of therapy for antifungal therapy for neutropenia?

A

2 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
94
Q

When should antiviral therapy be initiated for neutropenia?

A

-vesicular/ulcerative skin or mucosal lesions OR
-presumed or confirmed viral infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
95
Q

What is the treatment for HSV/VZV?

A

-acyclovir
-valacyclovir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
96
Q

What patients are eligible for neutropenia prophylaxis?

A

-moderate- or high-risk patients with expected ANC ≤ 100 cells/mm^3 for > 7 days
-heme malignancies
-allogeneic and autologous hematopoietic stem cell transplants
-graft versus host disease with high-dose steroids
-alemtuzumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
97
Q

What are treatment options for neutropenia prophylaxis?

A

-ciprofloxacin
-levofloxacin
-Bactrim

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
98
Q

What is the HIV viral protein?

A

gp120

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
99
Q

What are the stages of HIV infection?

A

-acute retroviral syndrome
-chronic HIV infection
-AIDS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
100
Q

What are the routes of transmission of HIV?

A

-exposure of mucous membrane or damaged tissue to infected body fluids
-bloodstream exposure to infected body fluids
-mother-to-child

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
101
Q

What is the seroconversion window for the OraQuick In-Home test?

A

3 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
102
Q

What is the CD4 cell count cutoff for HIV vs. AIDS?

A

200 cells/mm^3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
103
Q

What is the CD4 percentage cutoff for HIV vs. AIDS?

A

14%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
104
Q

What is the mechanism of action of nucleoside reverse transcriptase inhibitors?

A

synthetic purine and pyrimidine analogues resulting in elongation termination of growing proviral DNA chain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
105
Q

What medications are nucleoside reverse transcriptase inhibitors?

A

-abacavir
-emtricitabine
-tenofovir
-vudine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
106
Q

What is the mechanism of action of non-nucleoside reverse transcriptase inhibitors?

A

bind to allosteric site of reverse transcriptase enzyme (reduces functionality)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
107
Q

What medications are non-nucleoside reverse transcriptase inhibitors?

A

-vir-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
108
Q

What is the mechanism of action of protease inhibitors?

A

inhibit viral protease (prevents assembly, maturation, and release of new virions)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
109
Q

What is the suffix of protease inhibitors?

A

-navir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
110
Q

What is the mechanism of action of integrase strand transfer inhibitors?

A

inhibit HIV integrase (prevents proviral DNA integration into host cell genome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
111
Q

What is the suffix of integrase strand transfer inhibitors?

A

-tegravir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
112
Q

What is the mechanism of action of attachment inhibitors?

A

binds to gp120

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
113
Q

What drug is an attachment inhibitor?

A

temsavir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
114
Q

What is the mechanism of action of post-attachment inhibitors?

A

binds to domain D2 of CD4 receptor on T cells and interrupts post-attachment steps required for entry of HIV into host cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
115
Q

What drug is a post-attachment inhibitor?

A

ibalizumab-uiyk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
116
Q

What is the mechanism of action of chemokine receptor (CCR5) antagonists?

A

-binds to CCR5 on CD4 receptors on T cells
-blocks binding of gp120
-prevents entry of HIV into host cell

117
Q

What drug is a chemokine receptor (CCR5) antagonist?

118
Q

What is the mechanism of action of capsid inhibitors?

A

binds to interface between capsid protein (p24) subunits (interferes with multiple steps of viral lifecycle)

119
Q

What drug is a capsid inhibitor?

A

lenacapavir

120
Q

What is the recommended dose of dolutegravir for integrase strand transfer inhibitor-naive?

A

50 mg PO QD

121
Q

What is the recommended dose of dolutegravir for integrase strand transfer inhibitor-experienced?

A

50 mg PO BID

122
Q

What HIV medication needs to be taken on an empty stomach at bedtime?

123
Q

What HIV medication needs to be titrated from 200 mg BID to 400 mg QD?

A

nevirapine

124
Q

What HIV medications need to be taken with food?

A

-etavirine
-rilpivirine
-atazanavir
-elvitegravir

125
Q

What HIV medication requires an oral lead-in phase for ≥ 28 days?

A

cabotegravir

126
Q

What HIV medication is administered IV?

A

ibalizumab

127
Q

What HIV medication is administered subcutaneous?

A

lenacapavir

128
Q

What are adverse effects of nucleoside reverse transcriptase inhibitors?

A

-mitochondrial toxicity
-lactic acidosis

129
Q

What is an adverse effect of non-nucleotide reverse transcriptase inhibitors?

130
Q

What are adverse effects of protease inhibitors?

A

-GI intolerance
-insulin resistance
-lipodystrophy

131
Q

What is an adverse effect of integrase strand transfer inhibitors?

A

weight gain

132
Q

How long should antacids be separated from PO INSTIs?

133
Q

What HIV medication cannot be administered with aluminum and magnesium?

A

raltegravir

134
Q

What HIV medication is contraindicated with PPIs?

A

rilpivirine

135
Q

What are the preferred benzodiazepines with protease inhibitors and cobicistat?

A

-lorazepam
-oxazepam
-temazepam

136
Q

What is the preferred corticosteroid with protease inhibitors and cobicistat?

A

beclomethasone

137
Q

What are the preferred statins with protease inhibitors and cobicistat?

A

-atorvastatin
-rosuvastatin
-pitavastatin
-pravastatin

138
Q

What is the dosing of PDE5 inhibitors with protease inhibitors and cobicistat?

A

low doses Q48-72H

139
Q

How long should polyvalent cation supplements be separated from integrase inhibitors?

140
Q

What class of HIV medications requires dosing adjustment in renal insufficiency?

A

nucleoside reverse transcriptase inhibitors

141
Q

What lab is required prior to initiation of abacavir?

A

HLA-B*5701 allele genetic testing

142
Q

What lab is required prior to initiation of maraviroc?

A

tropism assay

143
Q

What is the website for HIV treatment guidelines?

A

https://clinicalinfo.hiv.gov

144
Q

What are first-line initial treatment regimens for HIV?

A

-bictegravir/tenofovir alafenamide/emtricitabine (Biktarvy)
-dolutegravir/tenofovir alafenamide or tenofovir disoproxil fumarate/emtricitabine or lamivudine
-dolutegravir/lamivudine (Dovato)

145
Q

In what patients can dolutegravir/lamivudine not be administered to?

A

-HIV RNA > 500,000 copies/mL
-HBV co-infection
-ART started before results of HIV genotypic resistance testing or HBV testing available

146
Q

What viral load is needed for successful resistance test results?

A

> 500 copies/mL

147
Q

What HIV drug class has the lowest genetic barrier to resistance?

148
Q

What HIV drug class has the highest genetic barrier to resistance?

A

boosted PIs

149
Q

What are PEP treatment regimens?

A

-emtricitabine/tenofovir disoproxil fumarate 200/300 mg PO QD for 28 days AND
-raltegravir 400 mg PO BID OR dolutegravir 50 mg PO QD for 28 days

150
Q

What are PrEP treatment regimens?

A

-emtricitabine/tenofovir disoproxil fumarate 200/300 mg PO QD
-emtricitabine/tenofovir alafenamide 200/25 mg PO QD (MSM and transgender women who have sex with men)
-cabotegravir 600 mg IM once, then 1 month later, then Q2M

151
Q

What do fungal cells contain in the cell membrane instead of cholesterol like in mammalian cells?

A

ergosterol

152
Q

What enzyme do allylamines inhibit?

A

squalene epoxidase

153
Q

What step does squalene epoxidase catalyze?

A

squalene –> squalene epoxide

154
Q

What enzyme do azoles inhibit?

A

14 alpha-demethylase

155
Q

What step does 14 alpha-demethylase catalyze?

A

lanosterol –> ergosterol

156
Q

What drug class do amphotericin B and nystatin belong in?

157
Q

What is the mechanism of action of polyenes?

A

-bind to ergosterol to form pores for ions to leak out of cells
-withdraw ergosterol from membrane

158
Q

What drug class does terbinafine belong in?

A

allylamines

159
Q

What is the suffix of echinocandins?

160
Q

What is the mechanism of action of echinocandins?

A

inhibit synthesis of beta(1-3) glucan synthase

161
Q

How are echinocandins selective for fungal cells?

A

mammalian cells lack beta(1-3) glucan synthase

162
Q

What drug class does flucytosine belong in?

A

antimetabolites

163
Q

What is the mechanism of action of flucytosine?

A

inhibit thymidylate synthase

164
Q

How is flucytosine selective for fungal cells?

A

mammalian cells cannot convert flucytosine to active metabolite

165
Q

What is the mechanism of action of ibrexafungerp?

A

inhibits glucan synthase

166
Q

What is the mechanism of action of tavaborole?

A

inhibits leucyl transfer RNA synthetase (leuRS)

167
Q

How are amphotericin B and flucytosine synergistic agents?

A

amphotericin B creates pores to allow flucytosine to enter fungal cells more easily

168
Q

What is the first step of metabolism of flucytosine?

A

flucytosine –> 5-FU (catalyzed by cytosine deaminase)

169
Q

What are the second and third steps of flucytosine metabolism?

A

5-FU –> 5-FUMP –> 5-FdUMP (catalyzed by PRT and ribonucleotide reductase)

170
Q

What is the function of dTMP?

A

extends fungal DNA for cell growth

171
Q

What activates isoniazid?

172
Q

What is the mechanism of action of isoniazid?

A

-forms products with NAD+ and NADP+
-inhibits enzymes (InhA) that use NAD+ and NADP+
-inhibits mycolic acid synthesis

173
Q

What is the mechanism of action of rifampin?

A

-binds to RNA polymerase within DNA/RNA channel
-blocks path of elongating RNA

174
Q

What is the mechanism of action of ethambutol?

A

-inhibits mycobacterial arabinosyl transferase
-results in buildup of arabinan (inhibits formation of arabinogalactan and lipoarabinomannan)

175
Q

What activates pyrazinamide?

A

low pH and pncA

176
Q

What is the mechanism of action of pyrazinamide?

A

inhibits panD which leads to inhibition of coenzyme A synthesis

177
Q

What is the mechanism of action of bedaquiline?

A

inhibits ATP synthase

178
Q

What is a resistance mechanism of bedaquiline?

A

mutations in atpE

179
Q

What activates pretomanid?

A

deazaflavin-dependent nitroreductase (Ddn)

180
Q

What are the mechanisms of action of pretomanid?

A

-forms reactive metabolite that inhibits mycolic acid production (aerobic conditions)
-generates reactive nitrogen species (anaerobic conditions)

181
Q

At what stage of tuberculosis does a tuberculin skin test (TST) become positive?

A

infection eliminated with acquired immune response

182
Q

At what stage of tuberculosis does an interferon-gamma release assay (IGRA) become positive?

A

infection eliminated with acquired immune response

183
Q

At what stage of tuberculosis does a culture become intermittently positive?

A

subclinical TB disease

184
Q

At what stage of tuberculosis does a sputum smear become positive?

A

active TB disease

185
Q

At what stage of tuberculosis does a patient become infectious?

A

subclinical TB disease

186
Q

At what stage of tuberculosis does a patient present with symptoms?

A

subclinical TB disease

187
Q

At what stage of tuberculosis should treatment be initiated?

A

latent TB infection

188
Q

What TB drug should be avoided or used with caution if a patient has HIV and latent TB?

189
Q

What drugs are polyresistant TB not resistant to both of?

A

isoniazid and rifampin

190
Q

What drugs are used for the intensive phase of a standard six-month treatment of TB?

A

-rifampin 600 mg
-isoniazid 300 mg
-ethambutol 800 - 1600 mg
-pyrazinamide 1000 - 2000 mg

191
Q

How long is the intensive phase of a standard six-month treatment of TB?

192
Q

What drugs are used for the continuation phase of a standard six-month treatment of TB?

A

-rifampin 600 mg
-isoniazid 300 mg

193
Q

How long is the continuation phase of a standard six-month treatment of TB?

194
Q

What drugs are used for the intensive phase of a rifapentine-based four-month treatment?

A

-rifapentine 1200 mg
-isoniazid 300 mg
-moxifloxacin 400 mg
-pyrazinamide 1000 - 2000 mg

195
Q

How long is the intensive phase of a rifapentine-based four-month treatment?

196
Q

What drugs are used for the continuation phase of a rifapentine-based four-month treatment?

A

-rifapentine 1200 mg
-isoniazid 300 mg
-moxifloxacin 400 mg

197
Q

How long is the continuation phase of a rifapentine-based four-month treatment?

198
Q

What type of patients does Aspergillus primarily cause disease in?

A

immunocompromised hosts

199
Q

What are the two most common Cryptococcus bacteria?

A

-Cryptococcus neoformans
-Cryptococcus gattii

200
Q

What organ does Cryptococcus primarily affect?

201
Q

What fungi is amphotericin a first-line agent for?

A

-Cryptococcus
-Blastomyces
-Histoplasma
-Mucor

202
Q

What are common adverse effects of amphotericin?

A

-nephrotoxicity
-hypokalemia
-hypomagnesemia

203
Q

What is the bioavailability of flucytosine?

204
Q

Does flucytosine penetrate into the CSF?

205
Q

How much of flucytosine is excreted unchanged in the urine?

206
Q

What fungi is flucytosine a first-line agent for?

A

Cryptococcus

207
Q

What is a common adverse effect of flucytosine?

A

bone marrow suppression

208
Q

What are monitoring parameters for flucytosine?

A

-CBC
-platelets
-SCr
-BUN

209
Q

What is the bioavailability of fluconazole?

210
Q

Does fluconazole penetrate into the CSF?

211
Q

Does fluconazole require dosing adjustment in renal insufficiency?

212
Q

What body weight is fluconazole dosing based on?

A

total body weight

213
Q

What are indications for fluconazole?

A

-noninvasive candidiasis
-invasive candidiasis
-bone marrow transplant prophylaxis
-Cryptococcal meningitis

214
Q

What is the dose of fluconazole for invasive candidiasis caused by C. albicans?

A

800 mg (12 mg/kg) loading dose, then 400 mg (6 mg/kg) QD

215
Q

What is the dose of fluconazole for invasive candidiasis caused by C. glabrata?

A

1200 - 1600 mg loading dose, then 800 mg QD

216
Q

What are common adverse effects of fluconazole?

A

-headache
-nausea
-anorexia
-QTc prolongation
-elevation of hepatic transaminases
-adrenal insufficiency

217
Q

What fungi is fluconazole a first-line agent for?

A

-Candida albicans
-Candida parapsilosis
-Candida tropicalis
-Candida lusitaniae
-Coccidioides

218
Q

What are itraconazole and voriconazole predominantly metabolized by?

A

CYP450 enzymes

219
Q

What is the active metabolite of itraconazole?

A

hydroxyitraconazole

220
Q

How does clearance change with higher doses of itraconazole?

221
Q

What is absorption of itraconazole dependent on except for oral solutions?

A

gastric acidity

222
Q

What are indications for itraconazole?

A

-histoplasmosis
-blastomycosis

223
Q

What are common adverse effects of itraconazole?

A

-hepatotoxicity
-congestive heart failure (boxed warning)
-QTc prolongation

224
Q

What dosage form of posaconazole is absorption affected by gastric pH?

A

oral suspension

225
Q

What is the preferred oral formulation of posaconazole?

A

delayed release tablets

226
Q

When should posaconazole and voriconazole be avoided?

A

CrCL < 50 mL/min

227
Q

What are common adverse effects of posaconazole?

A

-N/V
-abdominal pain
-diarrhea
-QTc prolongation
-increased LFTs
-hypokalemia
-rash
-pseudohyperaldosteronism

228
Q

What dosage form of voriconazole does not require dosing adjustments for renal insufficiency?

A

oral formulations

229
Q

What drugs do not affect the oral bioavailability of voriconazole?

A

-H2RA
-PPI
-antacid

230
Q

What are indications for voriconazole?

A

-invasive aspergillosis
-Candida infections

231
Q

What are common adverse effects of voriconazole?

A

-visual disturbances
-elevated LFTs
-QTc prolongation
-phototoxic skin reactions
-diffuse painful periostitis

232
Q

What fungi is voriconazole a first-line agent for?

A

Aspergillus

233
Q

Which azole has the least number of drug interactions?

A

isavuconazole

234
Q

What is a contraindication for isavuconazole?

A

familial short QT syndrome

235
Q

What fungi are echinocandins first-line agents for?

A

-C. glabrata
-C. krusei
-C. lusitaniae
-C. auris

236
Q

What are common adverse effects of caspofungin?

A

-histamine-mediated symptoms
-fever
-phlebitis at infusion site
-N/V
-headache

237
Q

What is the route of administration for micafungin?

238
Q

Does micafungin require dosing adjustments for renal insufficiency?

239
Q

What are common adverse effects of micafungin?

A

-hyperbilirubinemia
-nausea
-diarrhea
-eosinophilia
-rash, pruritis, urticaria

240
Q

What is the indication for ibrexafungerp?

A

vulvovaginal candidiasis

241
Q

What is a contraindication for ibrexafungerp?

242
Q

When should effective contraception be used for ibrexafungerp treatment?

A

during and for 4 days after treatment

243
Q

What is the drug of choice for C. albicans?

A

fluconazole

244
Q

What is the drug of choice for C. glabrata?

A

echinocandin

245
Q

What is the drug of choice for C. parapsilosis?

A

fluconazole

246
Q

What is the drug of choice for C. tropicalis?

A

fluconazole

247
Q

What is the drug of choice for C. krusei?

A

echinocandin

248
Q

What are the drugs of choice for C. lusitaniae?

A

fluconazole and echinocandin

249
Q

What is the drug of choice for C. auris?

A

echinocandin

250
Q

What are the drugs of choice for Cryptococcus?

A

fluconazole, amphotericin, and flucytosine

251
Q

What is the drug of choice for Blastomyces?

A

itraconazole

252
Q

What is the drug of choice for Histoplasma?

A

itraconazole

253
Q

What is the drug of choice for Coccidioides?

A

fluconazole

254
Q

What is the drug of choice for Aspergillus?

A

voriconazole

255
Q

What is the drug of choice for Mucor?

A

amphotericin

256
Q

What is the primary defense against superficial Candida infections?

A

cell-mediated immunity

257
Q

What is the mechanism of action of pyrethrins?

A

bind to voltage-gated sodium channels in parasite nerve cells

258
Q

What is the mechanism of action of spinosad?

A

nicotinic acetylcholine receptor agonist

259
Q

What is the mechanism of action of benzimidazoles?

A

inhibit formation of microtubules

260
Q

What is the mechanism of action of pyrantel pamoate?

A

depolarizing neuromuscular blocking agent

261
Q

What are the mechanisms of action of artemisinin?

A

-forms free radicals
-inhibits PfPI3K

262
Q

What is the mechanism of action of chloroquine?

A

-binds to heme to form FP-chloroquine complex
-caps hemozoin molecules to prevent further biocrystallization of heme

263
Q

What is the mechanism of action of primaquine?

A

spontaneous oxidation to O-PQm which produces H2O2

264
Q

What is the mechanism of action of doxycycline in malaria?

A

blocks protein translation in apicoplast

265
Q

What are treatment options for malaria prophylaxis in all malaria-endemic regions?

A

-atovaquone/proguanil
-doxycycline
-tafenoquine

266
Q

When should atovaquone/proguanil and doxycycline be started for malaria prophylaxis?

A

1-2 days before departure

267
Q

How long should atovaquone/proguanil be continued for malaria prophylaxis?

A

7 days after leaving malaria endemic region

268
Q

When should be atovaquone/proguanil be avoided?

A

-CrCl < 30 mL/min
-pregnant women
-women breastfeeding infants < 5 kg
-children < 5 kg

269
Q

How long should doxycycline be continued for malaria prophylaxis?

A

4 weeks after leaving malaria endemic region

270
Q

When should doxycycline be avoided?

A

-pregnant women
-children < 8 years old
-tetracycline allergy
-women prone to vaginal yeast infections

271
Q

When should tafenoquine be started for malaria prophylaxis?

A

3 days before departure

272
Q

How long should tafenoquine be continued for malaria prophylaxis?

A

1 week after leaving malaria endemic region

273
Q

When should tafenoquine be avoided?

A

-G6PD deficiency or no test results
-pregnant or breastfeeding women
-psychotic disorders
-children

274
Q

What are treatment options for malaria prophylaxis in regions with chloroquine-sensitive malaria?

A

-chloroquine
-hydroxychloroquine

275
Q

When should chloroquine and hydroxychloroquine be started for malaria prophylaxis?

A

1-2 weeks before departure

276
Q

How long should chloroquine and hydroxychloroquine be continued for malaria prophylaxis?

A

4 weeks after leaving malaria endemic region

277
Q

What treatment is administered for malaria prophylaxis in regions primarily with Plasmodium vivax?

A

primaquine

278
Q

When should primaquine be started for malaria prophylaxis?

A

1-2 days before departure

279
Q

How long should primaquine be continued for malaria prophylaxis?

A

7 days after leaving malaria endemic region

280
Q

When should primaquine be avoided?

A

-G6PD deficiency or no test results
-pregnant or breastfeeding women

281
Q

What treatment is administered for malaria prophylaxis in regions with mefloquine-sensitive malaria?

A

mefloquine

282
Q

When should mefloquine be started for malaria prophylaxis?

A

≥ 2 weeks before departure

283
Q

How long should mefloquine be continued for malaria prophylaxis?

284
Q

When should mefloquine be avoided?

A

-mefloquine allergy
-active/recent depression
-recent history of psychiatric disorders or seizures
-cardiac conduction abnormalities

285
Q

What are treatment options for chloroquine or unknown resistance uncomplicated malaria?

A

-artemether-lumefantrine
-atovaquone-proguanil
-quinine sulfate AND doxycycline, tetracycline, or clindamycin

286
Q

What is the treatment option for chloroquine, no mefloquine, or unknown resistance uncomplicated malaria?

A

mefloquine

287
Q

What are the treatment options for chloroquine sensitive uncomplicated malaria?

A

-chloroquine
-hydroxychloroquine

288
Q

What are the treatment options for anti-relapse treatment for P. vivax and P. ovale infections?

A

-primaquine phosphate
-tafenoquine

289
Q

What is the treatment for severe malaria?

A

IV artesunate